Global Health
add_icon

Global Health

1,157.00
+11.90
(1.04%)
Market Cap
31,099.05 Cr
PE Ratio
59.88
Volume
26,711.00
Day High - Low
1,158.70 - 1,139.80
52W High-Low
1,456.50 - 1,010.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
31,099.05 Cr
EPS
17.92
PE Ratio
59.88
PB Ratio
8.30
Book Value
141.18
EBITDA
956.20
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
14.21
Debt to Equity
0.24
Analyst Rating and Forecast
- By Refinitiv from13 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+61.54 %
+61.54 %
Hold
Hold+38.46 %
+38.46 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
negative
Global Health reports consolidated net profit of ₹950 million for Q3, marking a significant decline from ₹1.43 billion in the same quarter last year, representing a 33.6% year-on-year decrease.
positive
Global Health Limited's Nomination and Remuneration Committee approved grant of 4,000 employee stock options under GHL LTIP 2024 Plan with exercise price of Rs. 2 per option.
neutral
Global Health Limited schedules earnings conference call for February 5, 2026 at 2:00 PM IST to discuss Q3FY26 results, hosted by JM Financial with senior management participation.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,590.00
#1 1,09,132.55
58.66
#1 21,994.30
14.76
#1 1,505
36.08
73.95
1,080.70
1,05,127.18
73.76
7,184.10
#1 28.65
1,076
26.01
61.79
912.95
68,923.90
70.48
7,849.70
13.25
809
-22.38
60.84
1,847.90
37,763.83
48.17
5,575.00
12.29
790
-34.33
53.23
622.85
32,271.17
89.52
4,286.70
15.12
337
-8.85
63.56
1,157.00
#6 31,099.05
#4 59.88
#6 3,771.40
#9 12.59
#5 481
#7 -33.52
52.88
699.30
27,981.72
87.03
3,067.00
21.98
415
-43.89
64.58
453.70
14,358.24
89.51
1,757.00
27.64
110
#1 54.61
43.50
1,220.00
12,390.22
#1 46.20
1,566.90
17.46
244
7.26
44.83
588.50
8,298.30
322.87
2,257.70
17.03
49
-201.28
41.45

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
12.59 %
Net Income Growth
0.67 %
Cash Flow Change
1.91 %
ROE
-13.62 %
ROCE
-9.67 %
EBITDA Margin (Avg.)
-2.80 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
492
588
593
533
627
695
706
732
795
865
855
836
883
975
960
954
1,051
1,135
1,143
Expenses
386
442
448
441
485
523
534
540
595
631
621
629
675
728
706
757
784
868
940
EBITDA
106
146
146
92
142
172
172
192
199
234
234
207
208
247
254
198
267
267
203
Operating Profit %
21 %
24 %
23 %
15 %
21 %
23 %
23 %
24 %
24 %
25 %
26 %
22 %
22 %
24 %
25 %
19 %
24 %
21 %
16 %
Depreciation
31
31
33
35
36
37
39
38
40
43
44
46
47
49
49
49
45
50
61
Interest
16
17
18
28
19
18
21
21
18
20
18
18
18
16
16
15
14
17
22
Profit Before Tax
58
98
95
29
87
117
112
133
141
171
172
143
144
181
189
133
208
200
120
Tax
16
31
25
12
28
31
32
32
39
45
49
16
37
50
46
32
49
41
25
Net Profit
42
67
70
18
59
86
81
101
102
125
124
127
106
131
143
101
159
158
95
EPS in ₹
5.13
13.22
2.76
0.69
2.32
3.38
3.08
3.77
3.80
4.66
4.61
4.74
3.96
4.87
5.32
3.77
5.92
5.89
3.54

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,984
2,430
0
2,694
3,146
4,116
4,304
4,766
Fixed Assets
1,094
1,194
0
1,616
1,776
2,050
2,236
2,514
Current Assets
472
489
0
502
812
1,580
1,509
1,533
Capital Work in Progress
317
666
0
464
439
327
388
533
Investments
0
0
0
0
0
0
0
3
Other Assets
573
570
0
615
930
1,739
1,681
1,716
Total Liabilities
1,984
2,430
0
2,694
3,146
4,116
4,304
4,766
Current Liabilities
334
296
0
405
420
573
618
619
Non Current Liabilities
432
839
0
907
1,110
1,115
781
760
Total Equity
1,217
1,296
0
1,382
1,616
2,428
2,906
3,388
Reserve & Surplus
1,136
1,214
0
1,300
1,565
2,375
2,852
3,333
Share Capital
81
49
0
50
51
54
54
54

Cash Flow

Cash Flow
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-20
3
14
87
-78
50
648
-343
-194
Investing Activities
-126
-241
-69
-249
-87
-239
-421
-342
-441
-721
Operating Activities
213
228
63
166
175
242
311
645
612
624
Financing Activities
-88
-7
9
97
-1
-81
160
346
-514
-97

Share Holding

% Holding
Sept 2021
Oct 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
35.04 %
35.03 %
33.08 %
33.08 %
33.08 %
33.07 %
33.06 %
33.05 %
33.04 %
33.04 %
33.04 %
33.03 %
33.03 %
33.01 %
33.01 %
33.01 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.69 %
0.00 %
12.09 %
12.94 %
12.20 %
12.47 %
11.76 %
11.54 %
11.40 %
10.53 %
DIIs
0.00 %
0.00 %
7.78 %
12.55 %
12.35 %
10.80 %
10.93 %
9.68 %
10.25 %
10.57 %
11.11 %
10.51 %
11.93 %
12.20 %
12.98 %
14.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
25.44 %
6.16 %
5.77 %
6.79 %
6.85 %
6.79 %
7.14 %
6.28 %
6.54 %
6.74 %
6.53 %
6.48 %
6.03 %
5.95 %
Others
64.96 %
64.97 %
33.69 %
48.21 %
48.80 %
49.34 %
38.48 %
50.48 %
37.47 %
37.16 %
37.10 %
37.24 %
36.75 %
36.77 %
36.58 %
36.51 %
No of Share Holders
47
48
2,86,944
1,21,407
1,07,120
1,09,798
1,16,627
1,24,775
1,66,253
1,55,307
1,49,722
1,48,633
1,54,688
1,56,372
1,55,806
1,51,241

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
03 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Aug 2024 1,306.70 1,209.25
19 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2024 1,191.50 1,113.90
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 1,073.35 1,032.55
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,001.20 1,042.50
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,203.60 1,241.80
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 1,355.40 1,339.10
22 Aug 2025 DIVIDEND Dividend
0.50 /share
22 Aug 2025 1,241.80 1,389.30
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 1,339.10 1,367.70
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 1,348.70 1,280.70
04 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2026 1,030.00 1,114.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 04, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 04, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 04, 2026
Financial Results For Third Quarter And Nine Months Ended December 31 2025.Feb 04, 2026
Board Meeting Outcome for Intimation Under Regulation 30 Of Listing Regulations.Feb 04, 2026
Announcement under Regulation 30 (LODR)-Meeting UpdatesFeb 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Board Meeting Intimation For Schedule Of Board Meeting For Third Quarter And Nine-Months Ended December 31 2025 Under Regulation 29 Of Listing Regulations.Jan 24, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating Assigned By SES ESG Research Private Limited.Jan 07, 2026
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Credit RatingDec 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 03, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2025
Announcement Under Regulation 30 Of Listing Regulations.Nov 07, 2025
Results For The Quarter & Half Year Ended September 30 2025Nov 07, 2025
Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing RegulationNov 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 01, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 31, 2025
Board Meeting Intimation for Schedule Of Board Meeting For Second Quarter And Half Year Ended September 30 2025 Under Regulation 29 Of Listing RegulationsOct 28, 2025
Announcement Under Regulation 30 Of Listing Regulations.Oct 25, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 17, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.24%
442
-0.02%
-0.03%
Tata Nifty Midcap 150 Index Fund Direct-Growth
0.24%
-222
-0.02%
-0.04%
DSP Nifty 500 Index Fund Direct-Growth
0.05%
51
0.05%
0.05%
Kotak Nifty Midcap 150 Index Fund Direct - Growth
0.24%
44
-0.02%
-0.03%
DSP Nifty Midcap 150 Index Fund Direct - Growth
0.24%
24
-0.02%
0.24%
Groww Nifty Midcap 150 Index Fund Direct - Growth
0.24%
21
-0.02%
-0.04%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.16%
9
-0.01%
0.16%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.04%
4
0.00%
-0.01%
ITI Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
UTI Children's Hybrid Fund-Direct Plan
0.25%
0
0.00%
-0.03%
Bandhan Nifty Midcap 150 Index Fund Direct-Growth
0.24%
0
0.00%
-0.02%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.04%
0
0.00%
-0.01%
Baroda BNP Paribas Nifty Midcap 150 Index Fund Direct-Growth
0.24%
0
0.00%
-0.02%
Canara Robeco Conservative Hybrid Fund Direct-Growth
0.75%
0
0.00%
-0.07%
Canara Robeco Large and Mid Cap Fund Direct-Growth
0.99%
0
0.00%
-0.08%
Canara Robeco Mid Cap Fund Direct - Growth
1.88%
0
0.00%
-0.23%
Canara Robeco Multi Cap Fund Direct - Growth
0.59%
0
0.00%
-0.07%
Canara Robeco Small Cap Fund Direct - Growth
1.06%
0
0.00%
-0.09%
Canara Robeco Value Fund Direct - Growth
0.85%
0
0.00%
-0.08%
Bandhan Healthcare Fund Direct - Growth
2.64%
0
-0.15%
2.64%
Bandhan Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
-0.03%
Edelweiss Business Cycle Fund Direct-Growth
0.00%
0
0.00%
-0.90%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct - Growth
0.61%
0
0.00%
-0.03%
Edelweiss NIFTY Large Mid Cap 250 Index Fund Direct - Growth
0.12%
0
0.00%
-0.01%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.69%
0
0.00%
-0.04%

Technical Indicators

RSI(14)
Neutral
51.74
ATR(14)
Less Volatile
39.33
STOCH(9,6)
Neutral
77.58
STOCH RSI(14)
Overbought
87.54
MACD(12,26)
Bullish
9.46
ADX(14)
Weak Trend
20.04
UO(9)
Bearish
57.18
ROC(12)
Uptrend And Accelerating
10.15
WillR(14)
Neutral
-26.50

About Global Health

Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over...more
Listing Date
16 Nov, 2022(3 Years, 32 days)
Chairperson NameNaresh Kumar Trehan